公司资料
Syros Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- SYRS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (+300.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
As of Aug 17, 2026, SYRS closed up 300.0% at $0.0004. No new same-company headline was identified in the current news window.
公司概览
业务概览
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Syros sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, target validation, and the ability to create a durable oncology story.
生物医药行业定位
Syros is a small-cap oncology catalyst name whose valuation depends on early data and strategic progress.
未来催化剂
- Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。